Biomarkers of HIV related central nervous system disease (Q37073672)

18 August 2017

1 reference

title

Biomarkers of HIV related central nervous system disease (English)

1 reference

ORCID Public Data File 2021

18 August 2017

0 references

0 references

0 references

1 reference

author name string

Bruce James Brew

series ordinal

1

1 reference

18 August 2017

Scott Lee Letendre

series ordinal

2

1 reference

18 August 2017

publication date

1 February 2008

1 reference

International Review of Psychiatry

18 August 2017

published in

1 reference

18 August 2017

volume

20

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

73-88

1 reference

Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Trophic factors in cerebrospinal fluid and spinal cord of patients with tropical spastic paraparesis, HIV, and Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals--correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

CSF markers for Alzheimer's disease: Total tau, phospho-tau and Aβ42

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Tumor necrosis factor receptor superfamily members and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Bioactive lipids in excitatory neurotransmission and neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

CSF amyloid beta42 and tau levels correlate with AIDS dementia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Immunological Markers in the Cerebrospinal Fluid of HIV-1-Infected Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: a correlation with blood-brain-barrier dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (sICAM-1) in patients with HIV-1 associated neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Cellular mechanisms of microbial proteins contributing to invasion of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Transforming growth factor beta and monocyte chemotactic protein-1 are elevated in cerebrospinal fluid of immunocompromised patients with HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

HIV-1 replication in the plasma and cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

CD14, new aspects of ligand and signal diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Tumour necrosis factor (TNF-alpha) and neurological disorders in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Elevated neurofilament levels in neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Unique monocyte subset in patients with AIDS dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Matrix metalloproteinases in neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Haptoglobin polymorphism, iron metabolism and mortality in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

TGF-beta1 prevents gp120-induced impairment of Ca2+ homeostasis and rescues cortical neurons from apoptotic death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Circulating proviral HIV DNA and HIV-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Feasibility assessment of cerebrospinal fluid from HIV-1-infected children for HIV proviral DNA and monocyte chemoattractant protein 1 alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Increased intrathecal release of soluble fractalkine in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Vascular endothelial growth factor (VEGF) is increased in serum, but not in cerebrospinal fluid in HIV associated CNS diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Evaluation of CSF glial fibrillary acidic protein (GFAP) as a putative marker for HIV-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

CSF soluble Fas correlates with the severity of HIV-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Cytokine expression in the brain during the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Cytokine dysregulation in HIV-associated neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Serum and cerebrospinal fluid levels of interleukin-18 in human immunodeficiency virus type 1-associated central nervous system disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701878082

10.1080/09540260701878082

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference